HRCM
KRTX

Hood River Capital Management’s Karuna Therapeutics, Inc. Common Stock KRTX Stock Holding History

Hood River Capital Management’s Portfolio KRTX Stock Details KRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-110,556
Closed -$18.7M – 142
2023
Q3 		$18.7M Sell
110,556
-142
-0.1% -$26.7K 0.6% 63
2023
Q2 		$24M Sell
110,698
-101,611
-48% -$21.8M 0.71% 60
2023
Q1 		$38.6M Sell
212,309
-20,350
-9% -$3.89M 1.25% 36
2022
Q4 		$45.7M Buy
232,659
+5,176
+2% +$1.11M 1.66% 19
2022
Q3 		$51.2M Buy
227,483
+103,331
+83% +$20.9M 1.96% 14
2022
Q2 		$15.7M Buy
124,152
+7,615
+7% +$875K 0.62% 61
2022
Q1 		$14.8M Buy
116,537
+401
+0.3% +$45.1K 0.49% 68
2021
Q4 		$15.2M Sell
116,136
-73
-0.1% -$9.44K 0.46% 69
2021
Q3 		$14.2M Sell
116,209
-4,566
-4% -$527K 0.44% 72
2021
Q2 		$13.8M Sell
120,775
-1,651
-1% -$193K 0.41% 79
2021
Q1 		$14.7M Sell
122,426
-11,955
-9% -$1.35M 0.47% 79
2020
Q4 		$13.7M Buy
134,381
+1,981
+1% +$184K 0.45% 84
2020
Q3 		$10.2M Sell
132,400
-12,857
-9% -$1.1M 0.44% 78
2020
Q2 		$16.2M Buy
145,257
+18,414
+15% +$1.6M 0.73% 53
2020
Q1 		$9.13M Buy
+126,843
New +$10.8M 0.52% 66

Other funds holding KRTX

Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
GA
General Atlantic New York $2.15B AUM 35.02% 1-Year Est. Return

Hood River Capital Management's KRTX Position: Q4 2023 in Review

Hood River Capital Management sold out of Karuna Therapeutics, Inc. Common Stock (KRTX) in Q4 2023, closing a stake of 110,556 shares — an estimated $18.7M sold.

Hood River Capital Management first reported a position in KRTX in Q1 2020 and held it in 15 quarters. The position peaked at $51.2M in Q3 2022. 328 funds tracked by Wall St. Rank hold KRTX as of Q4 2023.

  • Hood River Capital Management reported no remaining Karuna Therapeutics, Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
  • Hood River Capital Management sold 110,556 Karuna Therapeutics, Inc. Common Stock shares in Q4 2023, an estimated $18.7M.
  • Hood River Capital Management first reported a position in Karuna Therapeutics, Inc. Common Stock in Q1 2020 and held it in 15 quarters.
  • Hood River Capital Management's Karuna Therapeutics, Inc. Common Stock position peaked at $51.2M in Q3 2022.
  • 328 funds tracked by Wall St. Rank held Karuna Therapeutics, Inc. Common Stock as of Q4 2023.

Based on Hood River Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.